Abstract
Schizophrenia is a complex disease, with both genetic and environmental influence. Machine learning techniques can be used to associate different genetic variations at different genes with a (schizophrenic or non-schizophrenic) phenotype. Several machine learning techniques were applied to schizophrenia data to obtain the results presented in this study. Considering these data, Quantitative Genotype – Disease Relationships (QDGRs) can be used for disease prediction. One of the best machine learning-based models obtained after this exhaustive comparative study was implemented online; this model is an artificial neural network (ANN). Thus, the tool offers the possibility to introduce Single Nucleotide Polymorphism (SNP) sequences in order to classify a patient with schizophrenia. Besides this comparative study, a method for variable selection, based on ANNs and evolutionary computation (EC), is also presented. This method uses half the number of variables as the original ANN and the variables obtained are among those found in other publications. In the future, QDGR models based on nucleic acid information could be expanded to other diseases.
Keywords: Bioinformatics, Data mining, Machine learning, Neural networks, Schizophrenia, SNP, Support vector machines.
Current Topics in Medicinal Chemistry
Title:Applied Computational Techniques on Schizophrenia Using Genetic Mutations
Volume: 13 Issue: 5
Author(s): Vanessa Aguiar-Pulido, Marcos Gestal, Carlos Fernandez-Lozano, Daniel Rivero and Cristian R. Munteanu
Affiliation:
Keywords: Bioinformatics, Data mining, Machine learning, Neural networks, Schizophrenia, SNP, Support vector machines.
Abstract: Schizophrenia is a complex disease, with both genetic and environmental influence. Machine learning techniques can be used to associate different genetic variations at different genes with a (schizophrenic or non-schizophrenic) phenotype. Several machine learning techniques were applied to schizophrenia data to obtain the results presented in this study. Considering these data, Quantitative Genotype – Disease Relationships (QDGRs) can be used for disease prediction. One of the best machine learning-based models obtained after this exhaustive comparative study was implemented online; this model is an artificial neural network (ANN). Thus, the tool offers the possibility to introduce Single Nucleotide Polymorphism (SNP) sequences in order to classify a patient with schizophrenia. Besides this comparative study, a method for variable selection, based on ANNs and evolutionary computation (EC), is also presented. This method uses half the number of variables as the original ANN and the variables obtained are among those found in other publications. In the future, QDGR models based on nucleic acid information could be expanded to other diseases.
Export Options
About this article
Cite this article as:
Aguiar-Pulido Vanessa, Gestal Marcos, Fernandez-Lozano Carlos, Rivero Daniel and R. Munteanu Cristian, Applied Computational Techniques on Schizophrenia Using Genetic Mutations, Current Topics in Medicinal Chemistry 2013; 13 (5) . https://dx.doi.org/10.2174/1568026611313050010
DOI https://dx.doi.org/10.2174/1568026611313050010 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
IP6 (Inositol Hexaphosphate) as a Signaling Molecule
Current Signal Transduction Therapy Knowledge and Perceptions Towards Cardiovascular Disease Prevention Among Patients with Type 2 Diabetes Mellitus: A Review of Current Assessments and Recommendations
Current Diabetes Reviews Pro-Inflammatory Cytokines IL-1β and TNF-α are not Associated with Plasma Homocysteine Concentration in Alzheimer’s Disease
Current Alzheimer Research Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry Pediatric Heart Failure in the Developing World
Reviews on Recent Clinical Trials Statins in Bacteremia, Sepsis and Pneumonia: Have We Found the Holy Grail?
Recent Patents on Inflammation & Allergy Drug Discovery CD45 Regulated Signaling Pathways
Current Topics in Medicinal Chemistry The Role of the Chemokines in Myocardial Ischemia and Reperfusion
Current Vascular Pharmacology From Endothelial Dysfunction to Arterial Stiffness in Diabetes Mellitus
Current Diabetes Reviews Does Erythropoietin Always Win?
Current Medicinal Chemistry Chemometric Modeling of 5-Phenylthiophenecarboxylic Acid Derivatives as Anti-Rheumatic Agents
Current Computer-Aided Drug Design Chemical Biology: Past, Present and Future
Current Chemical Biology Asthma-COPD Overlap: A more Simplistic Approach
Current Respiratory Medicine Reviews Dietary Fat and Hypertension: A Novel Approach Through the Proteolytic Regulatory Enzymes of the Renin-Angiotensin-System
Cardiovascular & Hematological Agents in Medicinal Chemistry The Roles of MicroRNAs in Heart Diseases: A Novel Important Regulator
Current Medicinal Chemistry Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Pharmacological manipulation of peripheral vascular resistance in special clinical situations after pediatric cardiac surgery
Current Vascular Pharmacology Role of Statins in Diabetes Complications
Current Diabetes Reviews Arterial Wall Structure and Dynamics in Type 2 Diabetes Mellitus Methodological Aspects and Pathophysiological Findings
Current Diabetes Reviews Use of Corticosteroids in Critically Ill Septic Patients: A Review of Mechanisms of Adrenal Insufficiency in Sepsis and Treatment
Current Drug Targets